CONNECT WITH US
HealthTech

HealthTech

IDSA: Earlier introduction of HPV vaccine improves initiation, completion by age 13

Medical Xpress logo

Published on

Add as a preferred source on Google
IDSA: Earlier introduction of HPV vaccine improves initiation, completion by age 13

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Introducing the human papillomavirus (HPV) vaccine at ages 9 to 10 years rather than 11 to 12 years leads to a meaningful difference in initiation and completion of the vaccine series, including initiation and completion by age 13 years, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 21 to 24 in Washington, D.C.

Sean O'Leary, M.D., M.P.H., from the University of Colorado Denver Anschutz Medical Campus and Children's Hospital Colorado in Aurora, and colleagues examined the impact of switching HPV vaccine initiation from 11 to 12 years to 9 to 10 years in a cluster-randomized trial among 31 pediatric practices in Colorado and California from 2021 to 2026. Sixteen practices were randomly assigned to introduce the vaccine at ages 9 to 10 years and 15 practices at ages 11 to 12 years.

The researchers found that the median age at initiation and completion of the series was 11.0 and 12.2 years and 11.8 and 13.3 years in the 9- to 10-year-old arm and 11- to 12-year-old arm, respectively.

85, respectively, for 9 to 10 years versus 11 to 12 years).



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.